To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity (opens ClinicalTrials.gov)
- Sponsor
- Texas Tech University
- Enrolment
- 73
- Started
- 2019-01-08
- Last update
- 2023-12-04
Conditions: Obesity
Interventions: Saxenda®, Placebo